Cargando…
Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients
RATIONALE: Recent studies have revealed that the lung microbiota of critically ill patients is altered and predicts clinical outcomes. The incidence of invasive fungal infections, namely, invasive pulmonary aspergillosis (IPA), in immunocompromised patients is increasing, but the clinical significan...
Autores principales: | Hérivaux, Anaïs, Willis, Jesse R, Mercier, Toine, Lagrou, Katrien, Gonçalves, Samuel M, Gonçales, Relber A, Maertens, Johan, Carvalho, Agostinho, Gabaldón, Toni, Cunha, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867272/ https://www.ncbi.nlm.nih.gov/pubmed/34172558 http://dx.doi.org/10.1136/thoraxjnl-2020-216179 |
Ejemplares similares
-
Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age
por: Mercier, Toine, et al.
Publicado: (2018) -
P412 QuicGM Aspergillus Galactomannan Ag lateral flow assay as a practical aid to diagnose invasive Aspergillosis in high-risk hematology patients
por: Aerts, Robina, et al.
Publicado: (2022) -
A Mortality Prediction Rule for Hematology Patients with Invasive Aspergillosis Based on Serum Galactomannan Kinetics
por: Mercier, Toine, et al.
Publicado: (2020) -
Clinical manifestations and outcomes of pulmonary aspergillosis: experience from Pakistan
por: Iqbal, Nousheen, et al.
Publicado: (2016) -
Clinical characteristics, diagnosis, outcomes and lung microbiome analysis of invasive pulmonary aspergillosis in the community-acquired pneumonia patients
por: Ao, Zhi, et al.
Publicado: (2023)